Real-time enrollment status for this histiocytic neoplasms clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 10:38 AM UTC
| NCT Number | NCT06411821 |
| Recruiting Status | Recruiting |
| Condition | Histiocytic Neoplasms |
| Phase | PHASE2 |
| Target Enrollment | 38 participants |
| Active Locations | 8 sites in the US |
| Sponsor | Memorial Sloan Kettering Cancer Center |
| Last Updated on CT.gov | May 28, 2026 (May 28, 2026) |
As of August 31, 2026: Clinical trial NCT06411821 is currently recruiting participants. This phase2 study for histiocytic neoplasms is actively seeking new participants at 8 locations across the United States. The study is sponsored by Memorial Sloan Kettering Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06411821 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 8 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06411821 was last updated May 28, 2026 (May 28, 2026). HelloStudys verifies this status automatically.